Capital Analysts LLC’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,990
Closed -$425K 757
2019
Q4
$425K Buy
5,990
+195
+3% +$14.1K 0.04% 190
2019
Q3
$433K Sell
5,795
-60
-1% -$5.09K 0.05% 185
2019
Q2
$472K Sell
5,855
-515
-8% -$36.2K 0.05% 183
2019
Q1
$426K Buy
6,370
+1,484
+30% +$112K 0.05% 178
2018
Q4
$364K Buy
4,886
+266
+6% +$22K 0.05% 172
2018
Q3
$425K Buy
4,620
+35
+0.8% +$3.33K 0.05% 167
2018
Q2
$451K Sell
4,585
-375
-8% -$41.9K 0.05% 164
2018
Q1
$553K Hold
4,960
0.07% 158
2017
Q4
$510K Buy
4,960
+135
+3% +$13.4K 0.06% 158
2017
Q3
$454K Hold
4,825
0.06% 154
2017
Q2
$376K Buy
4,825
+620
+15% +$46.6K 0.05% 167
2017
Q1
$337K Sell
4,205
-410
-9% -$32.6K 0.05% 156
2016
Q4
$363K Hold
4,615
0.06% 161
2016
Q3
$360K Buy
4,615
+100
+2% +$7.25K 0.07% 153
2016
Q2
$310K Hold
4,515
0.06% 156
2016
Q1
$322K Buy
4,515
+725
+19% +$45.5K 0.06% 157
2015
Q4
$236K Sell
3,790
-3,790
-50% -$231K 0.05% 167
2015
Q3
$430K Buy
7,580
+3,940
+108% +$209K 0.08% 153
2015
Q2
$195K Buy
3,640
+285
+8% +$13.9K 0.04% 172
2015
Q1
$159K Sell
3,355
-435
-11% -$19.3K 0.03% 180
2014
Q4
$164K Sell
3,790
-300
-7% -$12.3K 0.04% 172
2014
Q3
$141K Buy
+4,090
New +$144K 0.03% 172

Other funds holding CMD

Capital Analysts LLC's CMD Position: Q1 2020 in Review

Capital Analysts LLC sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 5,990 shares — an estimated $425K sold.

Capital Analysts LLC first reported a position in CMD in Q3 2014 and held it in 22 quarters. The position peaked at $553K in Q1 2018. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Capital Analysts LLC reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Capital Analysts LLC sold 5,990 Cantel Medical Corporation shares in Q1 2020, an estimated $425K.
  • Capital Analysts LLC first reported a position in Cantel Medical Corporation in Q3 2014 and held it in 22 quarters.
  • Capital Analysts LLC's Cantel Medical Corporation position peaked at $553K in Q1 2018.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Capital Analysts LLC's 13F filing for Q1 2020, filed 8 May 2020.